Suzhou Sepax Technologies
688758
Juneway Electronic Technology
301458
Jiujiang Defu Technology
301511
Cubic Digital Technology
300344
Ningbo Shuanglin Auto Parts
300100
CN Stock MarketDetailed Quotes
600200 JiangSu WuZhong Pharmaceutical Development
- 8.51
- -0.27-3.08%
Market Closed Jan 10 15:00 CST
6.06BMarket Cap-160.57P/E (TTM)
8.83High8.50Low89.54KlotVolume8.78Open8.78Pre Close77.47MTurnover1.26%Turnover RatioLossP/E (Static)712.15MShares13.8852wk High3.37P/B6.05BFloat Cap6.9052wk Low9.66Limit Up710.88MShs Float42.34Historical High7.90Limit Down3.76%Amplitude1.56Historical Low--Dividend TTM8.65Avg Price57.97KlotAsk--Div YieldTTM100Lot Size29.94KlotBid
JiangSu WuZhong Pharmaceutical Development News
Jiangsu Wuzhong: Announcement of Jiangsu Wuzhong Pharmaceutical Development Co., Ltd. on completing the registration of industrial and commercial changes
Announcement of Jiangsu Wuzhong Pharmaceutical Development Co., Ltd. on completing the registration of industrial and commercial changes
Jiangsu Wuzhong: Announcement of Jiangsu Wuzhong Pharmaceutical Development Co., Ltd. on changing the company\'s continuous supervision sponsor representative
Announcement of Jiangsu Wuzhong Pharmaceutical Development Co., Ltd. on changing the company\'s continuous supervision and sponsor representative
Jiangsu Wuzhong: Announcement of Jiangsu Wuzhong Pharmaceutical Development Co., Ltd. on the implementation of repurchase and cancellation of some restricted shares
Jiangsu Wuzhong Pharmaceutical Development Co., Ltd. implementation notice on repurchase and cancellation of some restricted shares
Jiangsu Wuzhong: Announcement of Resolutions of the 2024 Fourth Extraordinary General Meeting of Shareholders of Jiangsu Wuzhong Pharmaceutical Development Co., Ltd.
Jiangsu Wuzhong: Legal Opinion of Zhejiang Tianze Law Firm on the 2024 Fourth Extraordinary General Meeting of Shareholders of Jiangsu Wuzhong Pharmaceutical Development Co., Ltd.
Legal Opinion of Zhejiang Tianze Law Firm on the 2024 Fourth Extraordinary General Meeting of Shareholders of Jiangsu Wuzhong Pharmaceutical Development Co., Ltd.
Announcement of Resolutions of the 2024 Fourth Extraordinary General Meeting of Shareholders of Jiangsu Wuzhong Pharmaceutical Development Co., Ltd.
Jiangsu Wuzhong: Announcement of Jiangsu Wuzhong Pharmaceutical Development Co., Ltd. on the progress of providing guarantees for its wholly-owned subsidiary
Announcement of Jiangsu Wuzhong Pharmaceutical Development Co., Ltd. on the progress of providing guarantees for its wholly-owned subsidiaries
Announcement of Jiangsu Wuzhong Medicine Development Co., Ltd. on the participation of the Suzhou Pharmaceutical Factory of Jiangsu Wuzhong Pharmaceutical Group Co., Ltd. in the national centralized procurement of drugs to win the bid
Jiangsu Wuzhong: Documents of the 2024 Fourth Extraordinary General Meeting of Shareholders of Jiangsu Wuzhong Pharmaceutical Development Co., Ltd.
Documents of the 2024 Fourth Extraordinary General Meeting of Shareholders of Jiangsu Wuzhong Pharmaceutical Development Co., Ltd.
Independent Director Candidate Statements and Commitments
Independent Director Nominee Statements and Commitments
Announcement of Resolutions of the Fourth Interim Meeting of the 11th Board of Directors of Jiangsu Wuzhong Pharmaceutical Development Co., Ltd. in 2024 (Communications Vote)
Announcement of Jiangsu Wuzhong Pharmaceutical Development Co., Ltd. on the resignation of an independent director and the by-election of an independent director
Notice of Jiangsu Wuzhong Pharmaceutical Development Co., Ltd. on convening the 4th Extraordinary General Meeting of Shareholders of the Company in 2024
